Developing TherapiesTo Transform Lives
Astellas Gene Therapies is an Astellas Center of Excellence developing genetic medicines with the potential to deliver transformative value for patients.
Innovative Therapies
Our investigational therapies target rare diseases through three modalities: gene replacement, exon skipping gene therapy and vectorized RNA knockdown.
Employees: 201-500
Total raised: $337.5M
Founded date: 2012
Investors 7
| Date | Name | Website |
| - | Asset Mana... | assetman.c... |
| - | Aisling Ca... | aislingcap... |
| - | 5AM Ventur... | 5amventure... |
| - | Foresite C... | foresiteca... |
| - | Hercules C... | htgc.com |
| - | RA Capital... | racap.com |
| - | Sofinnova ... | sofinnova.... |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 25.01.2018 | - | $200M | - |
| 13.10.2015 | Series C | $65M | - |
| 02.12.2014 | Series B | $42.5M | - |
| 18.07.2013 | Series A | $30M | - |
Mentions in press and media 15
| Date | Title | Description | Source |
| 28.06.2020 | Two patients die in Audentes gene therapy study, heightening... | Two patients in a study of a high-dose gene therapy for a rare muscle disorder have died, heightenin... | statnews.c... |
| 26.08.2016 | Sofinnova Ventures has raised $595M for its largest fund to ... | The company’s strategy of investing in late-stage private companies has found some receptive buyers ... | medcitynew... |
| 04.01.2016 | Biotech Startups Hit the Ground Running, With Six Filing IPO... | If we had to gamble on it, we’d bet the IPO market will be far more brisk this year than last year, ... | techcrunch... |
| 13.10.2015 | Audentes Therapeutics Closes $65M Series C Financing | Audentes Therapeutics, Inc., a San Francisco, CA-based biotechnology company committed to the develo... | finsmes.co... |
| 13.10.2015 | Daily funding roundup - October 13, 2015 | EverString raised $65M; Audentes Therapeutics bagged $65M; SteelBrick received $48M Predictive marke... | vator.tv/n... |
| 13.10.2015 | Gene therapy player Audentes Therapeutics raises $65M | The round was led by existing investor Sofinnova Ventures and new investor Redmiel Group. Other part... | medcitynew... |
| 04.12.2014 | West Coast Biotech Roundup: Amgen, Ariosa, Avanir, Audentes ... | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Where is biotech innovation? All ov... | xconomy.co... |
| 02.12.2014 | Audentes Therapeutics Closes $42.5M Series B Financing | Audentes Therapeutics, Inc., a San Francisco, CA-based biotechnology company committed to the develo... | finsmes.co... |
| 02.12.2014 | AUDENTES THERAPEUTICS RAISES $42.5 MILLION IN SERIES B FINAN... | - | 5amventure... |
| 18.10.2013 | Health IT deals help push software deals to 12-year high but... | Here were the biggest health IT deals for the quarter based on data from the MoneyTree Report and Me... | medcitynew... |
Show more